The aim of the project is to evaluate genetic, miRNA and metabolic factors related to clinical CMT diversity and severity and to characterize the neurofilament light chain level and metabolic factors related to the CMT disease progression.
|Effective start/end date||1/09/20 → 31/08/21|
- Riga Stradins University: €20,000.00
- Charcot-Marie-Tooth disease
- hereditary neuropathy
Field of Science
- 3.2 Clinical medicine
Smart Specialization Area
- Biomedicine, medical technologies and biotechnology
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.